The term appears in nearly every product brief, vendor pitch, and conference presentation in health tech this year. "AI native." Two words that are supposed to communicate something meaningful about how a product was built and what it can do. In practice, the label is applied so broadly that it has almost stopped conveying information. 

An ambient documentation tool built on basic automatic speech recognition is called AI native. A medical coding engine that runs a rules-based lookup with a machine-learning layer is called AI-native. A clinical decision support tool trained on a proprietary dataset in 2019 is called AI native. The term stretches to fit everything, which means it helps buyers evaluate very little. 

That is a problem worth addressing, because the architecture behind an AI product in healthcare is not a marketing distinction. It determines accuracy, adaptability, liability exposure, and the degree to which human oversight remains meaningful rather than ceremonial. 

What AI Native Actually Means 

Percy Bhathena, VP of Product and AI at DeliverHealth, offered a working definition:

When we talk about AI native, we're really talking about frontier tools, but still as an augment to the human part of it. It's not old-school machine learning or ASR engines. It's large language models tuned for the clinician encounter.

That definition has three components worth examining separately. 

First: frontier models. AI native products are built on large language models, the same class of technology that has demonstrated qualitatively different capabilities in natural language understanding compared to prior generations of ML or ASR. ASR converts speech to text with reasonable accuracy but no clinical understanding. A large language model trained on clinical encounter data understands context, follows clinical reasoning, and can generate structured output from an unstructured conversation. 

Second: tuned for the clinical use case. General-purpose large language models are not AI native healthcare products without significant clinical fine-tuning. The training data, the evaluation criteria, the edge case handling, and the integration with clinical workflows are where meaningful differentiation actually lives. A model that understands colloquial conversation does not automatically understand clinical documentation requirements, specialty-specific terminology, or the downstream coding implications of how a diagnosis is stated. 

Third, and most important: augment to humans. This is the component that gets dropped from most vendor definitions, because acknowledging it requires acknowledging a limitation. AI native does not mean autonomous. It does not mean the human is removed from the workflow. It means the AI is doing the cognitive heavy lifting while the clinician retains judgment and accountability. 

What It Doesn't Mean 

AI native does not mean fully autonomous coding, documentation, or clinical decision-making. The products marketed as fully autonomous, in which the AI acts and humans review only exceptions, are making a claim that current large language model performance in clinical settings does not consistently support. 

Percy Bhathena was direct about this:

We're not trying to displace human thought, human logic, human judgment. We want to surface the things that allow for those judgments to be as accurate as possible.

That is a different value proposition than removing the human from the workflow. In ambient documentation, the AI produces a structured clinical note from the encounter conversation, and the physician approves it before it is entered into the record. In medical coding, it means the AI processes clinical documentation and surfaces code suggestions for a coder or CDI specialist to review before the claim goes out. The AI compresses the work and improves the starting point while the human review step remains intact. 

Why the Distinction Matters in Healthcare 

Most software categories can absorb the occasional inference error without material consequence. Healthcare operates differently. Medical coding relies on approximately 70,000 rules, and an incorrect inference at the code level can send a claim out incorrectly. Clinical documentation underpins the patient record and carries legal accountability, meaning errors in the AI's output are not just inefficiencies; they become part of the clinical record. 

AI-native products, properly defined, account for this by treating human review as the point of the workflow rather than an exception path. The AI exists to make the clinician more accurate and less burdened by documentation work that does not require clinical training. The clinician exists to apply the judgment that AI cannot reliably supply. 

The broader implication for health systems evaluating vendors is clear: a vendor promising fully autonomous operation, with no meaningful human review loop, is describing a product architecture that trades known risks for a cleaner pitch. That tradeoff is worth understanding before a contract is signed. 

Five Questions to Ask Any AI Native Vendor 

When evaluating ambient AI or medical coding vendors that describe their products as AI-native, these questions move the conversation beyond the label to the architectural reality. 

1. What model generation powers the product, and how was it clinically fine-tuned? 

2. Where does human review occur in the workflow, and can it be bypassed? 

3. How does the product handle inference gaps, where the encountered information is ambiguous or incomplete? 

4. What does accuracy look like broken down by encounter type and specialty, rather than as a single headline figure? 

5. When the AI produces an incorrect output, what is the correction process, and what audit trail does it leave? 

Vendors with genuinely AI-native architecture will answer all five with specificity. Vendors who redirect to headline numbers or describe human review as optional are telling you something important about their product design. 

AI Native Is a Starting Condition 

The label will keep spreading because it carries commercial value, and products will keep claiming it because buyers are asking for it. The more productive approach is to treat AI native as a baseline expectation for any serious clinical AI product in 2026 and focus the evaluation on what the vendor has built on top of it. 

The differentiation that matters is whether the product was genuinely built for clinical workflows and whether the vendor will have an honest conversation about where AI inference ends, and human judgment is required. Treating the label as a destination misses the point. It describes an architectural starting condition, and the quality of what follows determines whether the product delivers. 

DeliverHealth builds InstaNote and InstaCode on this architecture. InstaNote is DeliverHealth's ambient AI documentation platform, built on large language models tuned for the clinical encounter and designed to produce structured, EHR-ready notes while keeping the physician in the review loop. InstaCode is DeliverHealth's AI medical coding solution, built to surface code from clinical documentation with a human review step embedded in the workflow rather than bolted on as an afterthought. Together, they form a connected system from clinical conversation to the paid claim. For health systems, evaluating how ambient documentation and coding work together as a connected system, DeliverHealth's AI RCM page is a good place to start.